Supplier's Corner

Enzymotec Announces New DHA-Based Supplement

October 31, 2005

Enzymotec has developed a new DHA-delivery system that is capable of improving DHA bio-availability.
Earlier this year Enzymotec had concluded an animal and human study on a proprietary structured derivative of the DHA-phospholipid system, exhibiting a better DHA availability over fish DHA or mixtures of DHA and phospholipids and consequently a superior biological effect, thus supporting past scientific literature and the benefits of using advanced DHA delivery systems.
Enzymotec, a lipid nutrition company, is the developer and producer of CardiaBeat for CVD prevention, SharpPS for cognitive enhancement, and InFat for better calcium and energy absorptions as well as easy digestion for infants. More info: Orly Farkash, orly@enzymotec.com; 972-4-6545112.
blog comments powered by Disqus
  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.

  • What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 24, 2016
    Euromonitor weighs in on the implications for consumer product companies.

  • Henkel Grabs the Sun

    Henkel Grabs the Sun

    Ian Bell, Euromonitor International||June 24, 2016
    Euromonitor's Ian Bell on the impact the purchase will have on the US detergent industry.

  • To The Max

    To The Max

    Melissa Meisel, Associate Editor||June 20, 2016
    Velvet 59 is on the rise at locations like Ricky’s NYC.